Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05101889
What this trial is testing

Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation

Who this might be right for
Oral Mucositis
Prince of Songkla University 110
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Not applicableStudy completedNCT00415025
What this trial is testing

Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerLong-term Effects Secondary to Cancer Therapy in AdultsOral Complications of Radiation Therapy+1 more
University of Wisconsin, Madison 20
Not applicableLooking for participantsNCT05517135
What this trial is testing

TReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

Who this might be right for
Nasopharyngeal Carcinoma
National Cancer Centre, Singapore 1,000
Early research (Phase 1)Study completedNCT01254617
What this trial is testing

Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)UnknownNCT01245959
What this trial is testing

Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 476
Large-scale testing (Phase 3)UnknownNCT05757479
What this trial is testing

Steroid-Eluting Stent Implant for the Treatment of Radiation-Related Sinusitis

Who this might be right for
Radiation-Induced Mucositis
Sun Yat-sen University 168
Early research (Phase 1)Not Yet RecruitingNCT06383507
What this trial is testing

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+4 more
Zhejiang University 18
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Post-approval studies (Phase 4)UnknownNCT02948699
What this trial is testing

A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients

Who this might be right for
Malignant Neoplasm of Nasopharynx
Zhejiang Cancer Hospital 114
Not applicableStudy completedNCT00482872
What this trial is testing

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 400
Large-scale testing (Phase 3)Study completedNCT01540136
What this trial is testing

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 402
Large-scale testing (Phase 3)Looking for participantsNCT07235319
What this trial is testing

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC

Who this might be right for
Nasopharangeal CancerDistant Metastasis
Sun Yat-sen University 260
Testing effectiveness (Phase 2)Looking for participantsNCT06912711
What this trial is testing

TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 70
Testing effectiveness (Phase 2)Study completedNCT00720304
What this trial is testing

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 43
Early research (Phase 1)Study completedNCT04636632
What this trial is testing

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 100
Not applicableLooking for participantsNCT07412314
What this trial is testing

Proton Therapy for Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Guangzhou Concord Cancer Center 52
Not applicableStudy completedNCT01487733
What this trial is testing

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 155
Early research (Phase 1)Study completedNCT01324479
What this trial is testing

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 131
Testing effectiveness (Phase 2)Study completedNCT02608073
What this trial is testing

Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Hoffmann-La Roche 45
Next Page